Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve unaudited (Standalone and Consolidated) financial results for the quarter ended on June 30, 2025.